BiotechTube
Home/ImmuPharma/Lisa Baderoon
LB

Lisa Baderoon

Non-Executive Director & Head of Investor Relations

ImmuPharma

Therapeutic Areas

Autoimmune DiseasesType 1 Diabetes

ImmuPharma Pipeline

DrugIndicationPhase
P140 (Lupuzor)Systemic Lupus Erythematosus (SLE) / Autoimmune DiseasesPhase 2
KapiglucagonType 1 Diabetes (for use in artificial pancreas)Pre-clinical

Leadership Team at ImmuPharma

KP
Ketan Patel
Independent Non-Executive Director
DL
Dr. Laurence Reilly
Senior Independent Non-Executive Director, Chair of Audit Committee
View full ImmuPharma profile